puc-header

The GTPase Domain of MX2 Interacts with HIV-1 Capsid Enabling Its Short Isoform to Moderate Antiviral Restriction

49 Pages Posted: 24 Apr 2019 Publication Status: Published

See all articles by Gilberto Betancor

Gilberto Betancor

King’s College London - Department of Infectious Diseases

Matthew DJ Dicks

King’s College London - Department of Infectious Diseases

Jose M. Jimenez-­Guardeño

King’s College London - Department of Infectious Diseases

Nabil H. Ali

King’s College London - Department of Infectious Diseases

Apolonia L.

King’s College London - Department of Infectious Diseases

Michael H. Malim

King’s College London - Department of Infectious Diseases

More...

Abstract

Myxovirus resistance 2 (MX2/MXB) is an interferon (IFN)-induced HIV-1 restriction factor that inhibits viral nuclear DNA accumulation. The amino-terminal domain of MX2 binds the viral capsid and is essential for inhibition. Using in vitro assembled Capsid-Nucleocapsid (CANC) complexes as a surrogate for the HIV-1 capsid lattice, we reveal that the GTPase (G) domain of MX2 contains a second, independent capsid binding site. The importance of this interaction was addressed in a series of competition assays using the naturally occurring non-antiviral short isoform of MX2 that lacks the amino-terminal 25 amino acids. Specifically, we show that the G domain enhances MX2 function, and that the foreshortened isoform acts as a functional suppressor of the full-length protein in a G domain-dependent manner. The interaction of MX2 with its HIV-1 capsid substrate is therefore multi-faceted: there are dual points of contact which, together with protein oligomerization, contribute to the complexity of MX2 regulation.

Keywords: HIV-­1, MX2, capsid, GTPase domain, short isoform, antiviral activity

Suggested Citation

Betancor, Gilberto and Dicks, Matthew DJ and Jimenez-­Guardeño, Jose M. and Ali, Nabil H. and L., Apolonia and Malim, Michael H., The GTPase Domain of MX2 Interacts with HIV-1 Capsid Enabling Its Short Isoform to Moderate Antiviral Restriction (April 23, 2019). Available at SSRN: https://ssrn.com/abstract=3376665 or http://dx.doi.org/10.2139/ssrn.3376665
This version of the paper has not been formally peer reviewed.

Gilberto Betancor

King’s College London - Department of Infectious Diseases

United Kingdom

Matthew Dj Dicks

King’s College London - Department of Infectious Diseases

United Kingdom

Jose M. Jimenez-&Shy;GuardeÑO

King’s College London - Department of Infectious Diseases

United Kingdom

Nabil H. Ali

King’s College London - Department of Infectious Diseases

United Kingdom

Apolonia L.

King’s College London - Department of Infectious Diseases

United Kingdom

Michael H. Malim (Contact Author)

King’s College London - Department of Infectious Diseases ( email )

United Kingdom

Click here to go to Cell.com

Paper statistics

Downloads
23
Abstract Views
743
PlumX Metrics